Drug Registration in Pakistan
The registration process, dossiers and the role of DRAP's Registration Board.
Short notes and cheat sheetSubject guide
Regulatory Affairs MCQs for Pharmacy Exams
Drug registration, licensing, pricing and import control in Pakistan.
Regulatory affairs covers how medicines are authorised, licensed, priced and monitored before and after they reach the market. In Pakistan this work centres on the Drug Regulatory Authority of Pakistan (DRAP), and it is examined in Drug Inspector tests and in FPSC posts connected with drug regulation.
Questions focus on which body does what, the stages of registration and licensing, and international harmonisation standards. These regulatory affairs MCQs build a clear map of that system.
Topics covered
What Regulatory Affairs questions on PharmaPrep cover.
Pricing and Licensing
Establishment and manufacturing licences, and drug pricing policy.
Short notes and cheat sheetImport and Export Control
Controls on importing and exporting therapeutic goods.
Short notes and cheat sheetHigh-yield Regulatory Affairs topics
- Functions of DRAP under the DRAP Act 2012
- Difference between registration of a drug and licensing of a manufacturer
- Pharmacovigilance reporting in Pakistan
- ICH guidelines and their purpose
Exams that test Regulatory Affairs
Sample Regulatory Affairs MCQs
Original practice questions with answers and explanations.
1In Pakistan, registration of a drug before it can be marketed is granted through:
- AThe Registration Board of the Drug Regulatory Authority of Pakistan
- BThe Pharmacy Council of Pakistan
- CThe Provincial Health Department
- DThe Drug Court
Show answer and explanation
Answer: A. The Registration Board of the Drug Regulatory Authority of Pakistan
Drug registration is a function of DRAP, exercised through its Registration Board. The Pharmacy Council of Pakistan regulates pharmacy education and the registration of pharmacists, not of drugs.
2ICH, whose guidelines are widely used in drug regulation, stands for:
- AInternational Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
- BInternational Committee on Health
- CIntegrated Clinical Health standards
- DInternational Code of Hospital pharmacy
Show answer and explanation
Answer: A. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The ICH brings regulators and industry together to harmonise technical requirements for quality, safety and efficacy, such as the stability testing and good clinical practice guidelines.
3Registration of a drug and licensing of a manufacturer differ because:
- ARegistration authorises a specific product; licensing authorises premises to manufacture
- BThey are two names for the same approval
- CRegistration applies only to imported drugs
- DLicensing is required only for retail pharmacies
Show answer and explanation
Answer: A. Registration authorises a specific product; licensing authorises premises to manufacture
A drug is registered as a specific product with its formulation and specifications, while a licence authorises a firm and its premises to manufacture. A manufacturer normally needs both before a product can be produced and sold.
Regulatory Affairs FAQs
Which exams test regulatory affairs?
Drug Inspector tests and FPSC posts linked to drug regulation test it most, and it supports drug law questions in PPSC tests.
Should I study regulatory affairs with drug laws?
Yes. Regulation is carried out under the statutes, so studying the two together makes both easier to remember.
Do the MCQs reflect the current Pakistani system?
Questions are written around DRAP and the DRAP Act 2012. If a rule changes, report the question from the practice screen and it will be reviewed.